The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
GEINO 1402: A phase Ib dose-escalation study followed by an extension phase to evaluate safety and efficacy of crizotonib in combination with temozolomide (TMZ) and radiotherapy (RT) in patients with newly diagnosed glioblastoma (GB): Results of the dose-escalation phase.
 
Maria Martinez Garcia
Consulting or Advisory Role - Celgene; Roche
Speakers' Bureau - Pierre Fabre; Roche
Travel, Accommodations, Expenses - Celgene; Roche
 
Miguel J. Gil Gil
Honoraria - Novartis; Pfizer; Pierre Fabre; Roche
Consulting or Advisory Role - Novartis; Pfizer
Travel, Accommodations, Expenses - Roche
 
Estela Pineda Losada
Travel, Accommodations, Expenses - Amgen
 
Guillermo Velasco
Consulting or Advisory Role - GW Pharmaceuticals (Inst)
Speakers' Bureau - GW Pharmaceuticals
Research Funding - CellMid (Inst); GW Pharmaceuticals (Inst)
Patents, Royalties, Other Intellectual Property - GW Pharmaceuticals (Inst)
 
Francesc Alameda
No Relationships to Disclose
 
Alvaro Taus
No Relationships to Disclose
 
Jaume Capellades
No Relationships to Disclose
 
Ana Márquez-Martín
No Relationships to Disclose
 
Beatriz Sarmiento
Consulting or Advisory Role - Abbvie (Inst)
 
Carlos Mesia Barroso
No Relationships to Disclose
 
Jordi Bruna Escuer
No Relationships to Disclose
 
Eugenia Verger
No Relationships to Disclose
 
Aurelio Hernandez-Lain
No Relationships to Disclose
 
Manuel Guzman
Leadership - Functional Assessment of Chronic Illness Therapy; Thomas Jefferson University; Zelda Therapeutics
Patents, Royalties, Other Intellectual Property - Ciberned Spain; GW Pharmaceuticals (Inst); Yissum Israel
Travel, Accommodations, Expenses - Functional Assessment of Chronic Illness Therapy; Zelda Therapeutics
 
Juan Manuel Sepúlveda
Consulting or Advisory Role - Bayer; Janssen; Pfizer
Speakers' Bureau - Astellas Oncology
Research Funding - Pfizer
Travel, Accommodations, Expenses - Janssen